Sections
Shows
Events
Unregulated use of plasma therapy for COVID-19 can be harmful, writes expert; can expose patients to serious transfusion-related risks
Phase 3 results on Gilead coronavirus drug encouraging; a look at other potential COVID-19 treatments under trial
